Biostat Sp. z o.o
Biostat Sp. z o.o is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Efficacy comparison of two doses of vitamin D3 in critically ill patients undergoing continuous renal replacement therapy - NephroD
Sponsor Uniwersytecki Szpital Kliniczny W Opolu
- Start (EU)
- Latest update
- Estimated end
- Not reported
Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation (IRE-CaCl2, ECT and IRE) on quality of life and progression – free survival in patients with pancreatic cancer" (IREC).
Sponsor Wroclaw Medical University
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Biostat Sp. z o.o?
The 2026-10-09 snapshot links Biostat Sp. z o.o to 2 distinct CTIS trials. Recorded services include Clinical monitoring, Project management, Safety reporting & pharmacovigilance, Data management, among 7 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Biostat Sp. z o.o?
The most frequently recorded therapeutic areas are Critical Care, Nephrology, Nutrition. Recorded phases include Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Biostat Sp. z o.o conducted?
The linked trials record locations in 1 country, including Poland. These are trial locations, not confirmed office locations or countries where Biostat Sp. z o.o delivered services.
What can this page tell me about Biostat Sp. z o.o's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Biostat Sp. z o.o. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Biostat Sp. z o.o.